SYRE filings
Corporate insider profile
Sheldon Sloan Filing Activity
Latest reported as Chief Medical Officer of Spyre Therapeutics, Inc. (SYRE).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$6,225,674.83
- Latest transaction
- Jun 3, 2026
Affiliated corporations
Reported company relationships
Transaction history